Safety and efficacy of doxycycline in the treatment of rosacea
Author(s) -
Jorge L. Sánchez,
Sheila M Valentín,
Adisbeth Morales,
Antonio Rivera
Publication year - 2009
Publication title -
clinical cosmetic and investigational dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.73
H-Index - 35
ISSN - 1178-7015
DOI - 10.2147/ccid.s4296
Subject(s) - rosacea , doxycycline , minocycline , dermatology , medicine , etiology , erythema , tetracycline , disfigurement , surgery , acne , antibiotics , pathology , biology , microbiology and biotechnology
Rosacea is a common, chronic, skin condition characterized by recurrent episodes of facial flushing, transient or persistent erythema, papules, pustules, and telangiectasias, in a symmetrical facial distribution. The etiology of rosacea remains unknown and this condition represents a therapeutic challenge because of its chronic nature, progression, potential for disfigurement and psychological impact. Although there is no curative therapy for rosacea, the most widely used systemic agents are oral tetracycline derivatives, including tetracycline, doxycycline, and minocycline. This article reviews the available evidence for the use of doxycycline, a second-generation tetracycline, in the treatment or rosacea.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom